Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06294886 · ClinicalTrials.gov registry record
Vaginal Fluid Collection for Detection of Endometrial Cancer
A clinical trial of Endometrial Cancer, sponsored by Innovis.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06294886 is a study of Endometrial Cancer that is actively recruiting participants, run by Innovis. The registered enrollment target is 40 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06294886, a study of Endometrial Cancer, is actively recruiting participants, sponsored by Innovis.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to obtain de-identified vaginal fluid specimens from participants with an endometrial tissue biopsy-based histopathological diagnosis of endometrial cancer (EC), endometrial hyperplasia (AEH) with atypia or endometrial intraepithelial neoplasia (EIN). The samples will be used for the purpose of research and development of a new molecular diagnostic test for the detection of EC, AEH and EIN.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Screening test to detect endometrial cancer and precancer
Study Locations (1)
Louisiana
- Trials365 - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2024-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06294886
The ClinicalTrials.gov registry entry for NCT06294886 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Innovis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Screening test to detect endometrial cancer and precancer is the first listed.
NCT06294886 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06294886 about?
NCT06294886 is a clinical study titled "Vaginal Fluid Collection for Detection of Endometrial Cancer". The primary objective of this study is to obtain de-identified vaginal fluid specimens from participants with an endometrial tissue biopsy-based histopathological diagnosis of endometrial cancer (EC), endometrial hyperplasia (AEH) with atypia or endometrial intraepithelial neoplasia (EIN). The samp...
What is the current status of trial NCT06294886?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-02-19. Estimated completion is 2024-06-01.
What conditions does trial NCT06294886 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT06294886?
The interventions under investigation include: Screening test to detect endometrial cancer and precancer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06294886?
This trial is sponsored by Innovis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06294886 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.